Survival of Patients with Advanced Non-Small Cell Lung Cancer Enrolled in Clinical Trials

Publisher： Karger

E-ISSN： 1423-0232|91|4|185-193

ISSN： 0030-2414

Source： Oncology, Vol.91, Iss.4, 2016-07, pp. : 185-193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Benefit for Patients with Non-Small Cell Lung Cancer Enrolled in Phase I Trials

By  

Oncology Research and Treatment, Vol. 36, Iss. 6, 2013-05 ,pp. : 357-362

Karger

Access to resources Recommend Favorite

Comparison of Survival in Advanced Non-Small Cell Lung Cancer Patients in the Pre- and Post-Gefitinib Eras

By  

Oncology, Vol. 76, Iss. 4, 2009-02 ,pp. : 239-246

Karger

Access to resources Recommend Favorite

Inflammation‐Related Genetic Variations and Survival in Patients With Advanced Non–Small Cell Lung Cancer Receiving First‐Line Chemotherapy

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 3, 2014-09 ,pp. : 360-369

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relationship between icotinib hydrochloride exposure and clinical outcome in Chinese patients with advanced non–small cell lung cancer

By  

CANCER, Vol. 121, Iss. S17, 2015-09 ,pp. : 3146-3156

John Wiley & Sons Inc

Access to resources Recommend Favorite

EML4-ALK Rearrangement and Its Clinical Significance in Chinese Patients with Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 83, Iss. 5, 2012-09 ,pp. : 248-256

Karger

Access to resources Recommend Favorite